Immunotherapy with BCG in high risk recurrent bladder cancers previously treated with multiple cycles of chemotherapy: Long-term results

Acta Urologica Italica

Volumn 12, Issue 2, 1998, Pages 131-132

  Brausi, M ^a   Hurle, R ^a   Lembo, A ^a   Palladini, P D ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

BCG; High risk superficial bladder cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; EPIRUBICIN; MITOMYCIN C; PEPTICHEMIO; THIOTEPA;

ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG INSTILLATION; DYSURIA; FEVER; HEMATURIA; HIGH RISK POPULATION; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MICTURITION DISORDER; RECURRENT CANCER;

EID: 0031819685     PISSN: 03942511     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)